Curis Lifesciences (NSE:CURIS) EPS (Basic): ₹37.14 (TTM As of Mar. 2026)


NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
19 GF Score
Price ₹102.00
! 2 Warning Signs
View Full Analysis

What is Curis Lifesciences EPS (Basic)?

Curis Lifesciences NSE:CURIS -1.92% 19 EPS (Basic) is ₹37.14 as of Mar. 2026. GuruFocus rates NSE:CURIS with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Curis Lifesciences's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹37.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹37.14.

Curis Lifesciences's EPS (Diluted) for the six months ended in Mar. 2026 was ₹37.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹37.14.

Curis Lifesciences's EPS without NRI for the six months ended in Mar. 2026 was ₹37.65. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 37.65.

During the past 12 months, Curis Lifesciences's average EPS without NRIGrowth Rate was 427.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 183.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Curis Lifesciences's highest 3-Year average EPS without NRI Growth Rate was 183.60% per year. The lowest was 183.60% per year. And the median was 183.60% per year.

Curis Lifesciences  (NSE:CURIS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Curis Lifesciences EPS (Basic) Related Terms

Curis Lifesciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences EPS (Basic) Chart

Curis Lifesciences Annual Data
Trend Mar23 Mar24 Mar25 Mar26
EPS (Basic)
2.32 6.02 7.68 37.14

Curis Lifesciences Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
EPS (Basic) 2.32 6.02 7.68 37.14
NSE:CURIS
19GF Score
Curis Lifesciences Ltd NSE:CURIS
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Curis Lifesciences's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(69.163-0)/1.853
=37.32

Curis Lifesciences's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(69.163-0)/1.853
=37.32

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹37.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹37.14 mean?
Curis Lifesciences (NSE:CURIS) has a EPS (Basic) of ₹37.14 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Curis Lifesciences and its competitors.
Is Curis Lifesciences' EPS (Basic) too high?
Curis Lifesciences' current EPS (Basic) is ₹37.14. Overall, Curis Lifesciences has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' EPS (Basic) compare to ZTS?
Curis Lifesciences' EPS (Basic) of ₹37.14 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Curis Lifesciences and its competitors. Curis Lifesciences's current EPS (Basic) is ₹37.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current EPS (Basic) of ₹37.14. The current EPS (Basic) is ₹37.14. Curis Lifesciences' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current EPS (Basic) is ₹37.14 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
19GF Score

Get the complete analysis for NSE:CURIS

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹102.00
Price